Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Viral Hepat ; 11(4): 342-8, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15230857

ABSTRACT

Infection of the liver with hepatitis C virus (HCV) causes compartmentalization of CD8+ cytotoxic T cells to the site of disease. These cells are thought to be involved in viral clearance during interferon therapy. The repetitive analysis of the intrahepatic immune response is hampered by the difficulty to obtain the intrahepatic T cells. The fine-needle aspiration biopsy (FNAB) technique was evaluated for its use to obtain liver-derived CD8+ T cells in a minimally invasive way. In 26 chronic HCV patients who were evaluated for Peg-interferon and ribavirin combination therapy, pre-treatment FNABs and peripheral blood specimens were obtained simultaneously with liver tissue biopsies, and CD3+ and CD8+ T cells were quantified by immunocytochemistry. The CD8+/CD3+ ratio was significantly higher in the FNABs than in peripheral blood (P < 0.01), and similar to those in portal areas in the tissue biopsies. A significant correlation was observed between numbers of CD3+CD8+ T lymphocytes in the FNABs and the numbers of CD8+ cells in the lobular fields or in the portal tracts of the liver tissue biopsies, but not with CD3+CD8+ T lymphocytes in peripheral blood. Finally, the ratio of CD8+/CD3+ T lymphocytes in FNABs was significantly higher in those patients who responded rapidly to therapy when compared with slow responders at 4 weeks of treatment (P = 0.02). These findings demonstrate that the intrahepatic T-cell composition is reflected in FNABs, and that the FNAB technique can be used for predicting early virological response to therapy of patients chronically infected with HCV.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Hepatitis C, Chronic/pathology , Liver/pathology , Biopsy, Fine-Needle , Blood Cells/drug effects , CD3 Complex/analysis , CD8 Antigens/analysis , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/drug effects , Cell Count , Drug Therapy, Combination , Hepatitis C, Chronic/drug therapy , Hepatitis C, Chronic/immunology , Humans , Immunohistochemistry , Immunophenotyping , Interferon alpha-2 , Interferon-alpha/therapeutic use , Polyethylene Glycols/therapeutic use , Recombinant Proteins , Ribavirin/therapeutic use
2.
J Antimicrob Chemother ; 43(4): 511-5, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10350380

ABSTRACT

Successful treatment of Helicobacter pylori infection is becoming compromised by emerging resistance. We report the prevalence rates of H. pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. A total of 231 H. pylori clinical isolates were collected throughout the country over a period of 6 months during 1997-1998. The MICs of the above-mentioned antibiotics were determined in a single laboratory. The overall percentage of resistance for clarithromycin and metronidazole was 1.7% and 21.2%, respectively. None of the strains was resistant to amoxycillin or tetracycline. The primary resistance rate of trovafloxacin was as high as 4.7%. Since trovafloxacin has not yet been introduced on to the Dutch market, the resistance is probably induced by the use of other quinolones. Our data indicate that treatment outcome would benefit from susceptibility testing before starting therapy, especially when prescribing metronidazole.


Subject(s)
Anti-Bacterial Agents/pharmacology , Fluoroquinolones , Helicobacter Infections/microbiology , Helicobacter pylori/drug effects , Amoxicillin/pharmacology , Clarithromycin/pharmacology , Drug Resistance, Microbial , Drug Resistance, Multiple , Drug Utilization , Helicobacter Infections/drug therapy , Helicobacter pylori/growth & development , Helicobacter pylori/isolation & purification , Humans , Metronidazole/pharmacology , Microbial Sensitivity Tests , Naphthyridines/pharmacology , Netherlands , Tetracycline/pharmacology
3.
Oral Microbiol Immunol ; 14(1): 49-55, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10204480

ABSTRACT

Peptostreptococcus micros, which is associated with oral and non-oral mixed anaerobic infections, occurs in three colony morphotypes, the smooth type, the rough type and the smooth variant of the rough type. These types differ in surface structures; the rough type expresses large fibrillar surface appendages, which are absent on the surface of both the smooth and the smooth variant of the rough type. To determine the role of these surface structures in adherence we characterized the adherence of the three morphotypes of P. micros to epithelial cells in vitro. Although all three types adhered well to epithelial cells, adhering numbers of the rough type were significantly lower than those of the smooth and the smooth variant of the rough type. Protease treatment increased the adherence of the rough type of the level of the two other types. The adherence of all three types was reduced more than 85% by treatment with 10 mM sodium periodate. Furthermore, the adherence was pH independent and could not be blocked by incubation with antisera to the bacteria. In addition, we determined the capacity to invade epithelial cells by P. micros. In an acridine orange assay such invasion could not be detected. Our results suggest that the adherence of P. micros to epithelial cells is mediated by periodate-sensitive extracellular polysaccharides and that the protruding fibril-like protein surface structures of the rough type have an obstructive effect on the adherence.


Subject(s)
Bacterial Adhesion/physiology , Epithelial Cells/microbiology , Peptostreptococcus/physiology , Adhesins, Bacterial , Adult , Cells, Cultured , Epithelial Cells/physiology , Female , Gingiva/cytology , Gingiva/physiology , HeLa Cells , Humans , Hydrogen-Ion Concentration , KB Cells , Male , Middle Aged , Peptostreptococcus/classification , Periodontitis/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...